NEW YORK, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM). Investors who purchased Tandem securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TNDM. […]

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of C3.ai, Inc. ("C3.ai" or "the Company") (NYSE:AI). Investors who purchased C3.ai securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AI. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CPI Card Group Inc. ("CPI" or "the Company") (NASDAQ:PMTS). Investors who purchased CPI securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spirit Aviation Holdings, Inc. ("Spirit" or "the Company") (NYSE:FLYY). Investors who purchased Spirit securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ:LFMD). Investors who purchased LifeMD securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LFMD. Investigation Details

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flux Power Holdings, Inc. ("Flux" or "the Company") (NASDAQ:FLUX). Investors who purchased Flux securities prior to November 11, 2022, and continue to hold to the present, are encouraged to

NEW YORK, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / August 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged